FDA Inspection 1283228 — Kent A. Swaine, MD

Kent A. Swaine, MD — FEI 3031441760

The FDA completed an inspection of Kent A. Swaine, MD on September 19, 2025 in Las Vegas, NV. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 19, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Las Vegas, NV (United States)

Additional Details

Clinical BA/BE

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance